Overall Winner: Harrison.ai·68/ 100

Harrison.ai vs Predible Health

In-depth comparison — valuation, funding, investors, founders & more

Winner
H
Harrison.ai

🇦🇺 Australia · Aengus Tran

Series CAI HealthcareEst. 2018

Valuation

N/A

Total Funding

$129M

68
Awaira Score68/100

100-500 employees

Full Harrison.ai Profile →
P
Predible Health

🇮🇳 India · Sanjoy Paul

Series AAI HealthcareEst. 2017

Valuation

N/A

Total Funding

$5M

50
Awaira Score50/100

10-50 employees

Full Predible Health Profile →
🔬

Analyst Summary

Generated from real data · No AI hallucinations

Both Harrison.ai and Predible Health compete directly in the AI Healthcare space, making this a head-to-head matchup within the same market segment. Harrison. Predible Health develops AI software for radiology and medical imaging analysis, with a focus on automated CT scan interpretation for lung nodule detection, COVID-19 assessment, and liver segmentation.

Neither company has publicly disclosed a valuation at this time. On the funding side, Harrison.ai has raised $129M in total — $124M more than Predible Health's $5M.

Predible Health has 1 year more market experience, having been founded in 2017 compared to Harrison.ai's 2018 founding. In terms of growth stage, Harrison.ai is at Series C while Predible Health is at Series A — a meaningful difference for investors evaluating risk and upside.

Harrison.ai operates out of 🇦🇺 Australia while Predible Health is based in 🇮🇳 India, giving each a distinct home-market advantage. On Awaira's 0–100 composite score, Harrison.ai leads with a score of 68, reflecting stronger overall fundamentals across valuation, funding, and growth signals.

Metrics Comparison

MetricHarrison.aiPredible Health
💰Valuation
N/A
N/A
📈Total Funding
$129MWINS
$5M
📅Founded
2018WINS
2017
🚀Stage
Series C
Series A
👥Employees
100-500
10-50
🌍Country
Australia
India
🏷️Category
AI Healthcare
AI Healthcare
Awaira Score
68WINS
50

Key Differences

📈

Funding gap: Harrison.ai has raised $124M more ($129M vs $5M)

📅

Market experience: Predible Health has 1 year more (founded 2017 vs 2018)

🚀

Growth stage: Harrison.ai is at Series C vs Predible Health at Series A

👥

Team size: Harrison.ai has 100-500 employees vs Predible Health's 10-50

🌍

Market base: 🇦🇺 Harrison.ai (Australia) vs 🇮🇳 Predible Health (India)

⚔️

Direct competitors: Both operate in the AI Healthcare market segment

Awaira Score: Harrison.ai scores 68/100 vs Predible Health's 50/100

Which Should You Choose?

Use these signals to make the right call

H

Choose Harrison.ai if…

Top Pick
  • Higher Awaira Score — 68/100 vs 50/100
  • Stronger investor backing — raised $129M
  • Australia-based for regional compliance or proximity
  • Harrison
P

Choose Predible Health if…

  • More market experience — founded in 2017
  • India-based for regional compliance or proximity
  • Predible Health develops AI software for radiology and medical imaging analysis, with a focus on automated CT scan interpretation for lung nodule detection, COVID-19 assessment, and liver segmentation

Users Also Compare

FAQ — Harrison.ai vs Predible Health

Is Harrison.ai bigger than Predible Health?
Neither company has publicly disclosed a valuation, making a definitive size comparison difficult. Harrison.ai employs 100-500 people, while Predible Health has 10-50 employees.
Which company raised more funding — Harrison.ai or Predible Health?
Harrison.ai has raised more in total funding at $129M, compared to Predible Health's $5M — a gap of $124M.
Which company has a higher Awaira Score?
Harrison.ai holds the higher Awaira Score at 68/100, compared to Predible Health's 50/100. The Awaira Score is a composite metric factoring in valuation, funding, stage, team size, and market presence — a 18-point gap that reflects meaningful differences in scale or traction.
Who founded Harrison.ai vs Predible Health?
Harrison.ai was founded by Aengus Tran in 2018. Predible Health was founded by Sanjoy Paul in 2017. Visit each company's profile on Awaira for a full founder biography.
What does Harrison.ai do vs Predible Health?
Harrison.ai: Harrison.ai develops AI radiology and pathology analysis software for clinical deployment, building FDA-cleared and TGA-registered algorithms for chest X-ray abnormality detection, CT pulmonary angiography analysis, and mammography screening under its Annalise.ai product brand. The Sydney company focuses on AI clinical decision support that helps radiologists prioritise worklists, detect abnormalities, and reduce reporting errors in high-volume radiology departments.\n\nThe company raised approximately $129 million including a Series C from investors including Blackbird Ventures, Skip Capital, and Telstra Ventures. Harrison.ai has deployed its Annalise.ai platform across Australian hospital networks and has received US FDA clearance for its chest X-ray AI product, enabling international commercial expansion beyond Australia. The company has published clinical validation studies demonstrating AI performance that is non-inferior to specialist radiologist reads on chest X-ray abnormality detection across multiple institutions.\n\nHarrison.ai competes in the AI radiology market against Aidoc, Lunit, Qure.ai, and Behold.ai, which all target radiologist workflow assistance and clinical alerting. The Australian healthcare market provides a strong home base given the National Health Service framework and centrally coordinated radiology procurement, while FDA clearance opens the substantially larger US radiology AI market. The company is considered one of Australia most promising medical AI companies and a flagship for the Australian healthcare technology ecosystem. Predible Health: Predible Health develops AI software for radiology and medical imaging analysis, with a focus on automated CT scan interpretation for lung nodule detection, COVID-19 assessment, and liver segmentation. The platform integrates with radiology information systems and PACS to provide AI-assisted second reads and quantitative measurements that reduce reporting time and flag critical findings for urgent review.\n\nThe company raised approximately $5M in Series A funding and has established clinical partnerships with hospital networks and diagnostic imaging centers across India. Predible Health received significant validation through its COVID-19 CT analysis tool, which was deployed during the pandemic to help overwhelmed radiology departments manage surge volumes.\n\nRadiology AI represents one of the most commercially mature segments of medical AI globally, with clear clinical workflows, measurable radiologist productivity benefits, and established reimbursement pathways emerging in developed markets. Predible Health's India-focused deployments position it as a domestic alternative to global radiology AI companies, with the advantage of deep integration knowledge in Indian hospital IT environments.
Which company was founded first?
Predible Health was founded first in 2017, giving it 1 year of additional market experience. Harrison.ai was founded later in 2018. In AI, even a year or two of head start can translate into significantly more training data, customer relationships, and institutional knowledge.
Which company has more employees?
Harrison.ai has approximately 100-500 employees, while Predible Health has approximately 10-50. A larger team often signals higher revenue or venture backing, but in AI, smaller teams are increasingly capable of building at scale.
Are Harrison.ai and Predible Health competitors?
Yes, Harrison.ai and Predible Health are direct competitors — both operate in the AI Healthcare space and likely target overlapping customer segments. This comparison is especially relevant for buyers evaluating both platforms.